Ontology highlight
ABSTRACT: Background
Acinetobacter baumannii is one of the most life-threatening multidrug-resistant pathogens worldwide. Currently, 50%-70% of clinical isolates of A. baumannii are extensively drug-resistant, and available antibiotic options against A. baumannii infections are limited. There is still a need to discover specific de facto bacterial antigenic proteins that could be effective vaccine candidates in human infection. With the growth of research in recent years, several candidate molecules have been identified for vaccine development. So far, no public health authorities have approved vaccines against A. baumannii.Methods
This study aimed to identify immunodominant vaccine candidate proteins that can be immunoprecipitated specifically with patients' IgGs, relying on the hypothesis that the infected person's IgGs can capture immunodominant bacterial proteins. Herein, the outer-membrane and secreted proteins of sensitive and drug-resistant A. baumannii were captured using IgGs obtained from patient and healthy control sera and identified by Liquid Chromatography- Tandem Mass Spectrometry (LC-MS/MS) analysis.Results
Using the subtractive proteomic approach, we determined 34 unique proteins captured only in drug-resistant A. baumannii strain via patient sera. After extensively evaluating the predicted epitope regions, solubility, transverse membrane characteristics, and structural properties, we selected several notable vaccine candidates.Conclusion
We identified vaccine candidate proteins that triggered a de facto response of the human immune system against the antibiotic-resistant A. baumannii. Precipitation of bacterial proteins via patient immunoglobulins was a novel approach to identifying the proteins that could trigger a response in the patient immune system.
SUBMITTER: Acar MB
PROVIDER: S-EPMC9687788 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
Acar Mustafa Burak MB Ayaz-Güner Şerife Ş Güner Hüseyin H Dinç Gökçen G Ulu Kılıç Ayşegül A Doğanay Mehmet M Özcan Servet S
Frontiers in immunology 20221110
<h4>Background</h4><i>Acinetobacter baumannii</i> is one of the most life-threatening multidrug-resistant pathogens worldwide. Currently, 50%-70% of clinical isolates of <i>A. baumannii</i> are extensively drug-resistant, and available antibiotic options against <i>A. baumannii</i> infections are limited. There is still a need to discover specific <i>de facto</i> bacterial antigenic proteins that could be effective vaccine candidates in human infection. With the growth of research in recent year ...[more]